Cargando…
Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial
PURPOSE: To determine whether oral sedation is as safe and effective as IV sedation for ophthalmic surgeries other than cataract surgery, we tested whether patient satisfaction with oral triazolam was non-inferior to IV midazolam for cornea and glaucoma surgeries. PATIENTS AND METHODS: Seventy-five...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274777/ https://www.ncbi.nlm.nih.gov/pubmed/35837489 http://dx.doi.org/10.2147/OPTH.S354570 |
_version_ | 1784745360372006912 |
---|---|
author | Lee, Hyunjoo J Desai, Manishi A Sadlak, Natalie Fiorello, Marissa G Githere, Wanjiku G Subramanian, Manju L |
author_facet | Lee, Hyunjoo J Desai, Manishi A Sadlak, Natalie Fiorello, Marissa G Githere, Wanjiku G Subramanian, Manju L |
author_sort | Lee, Hyunjoo J |
collection | PubMed |
description | PURPOSE: To determine whether oral sedation is as safe and effective as IV sedation for ophthalmic surgeries other than cataract surgery, we tested whether patient satisfaction with oral triazolam was non-inferior to IV midazolam for cornea and glaucoma surgeries. PATIENTS AND METHODS: Seventy-five cornea and 49 glaucoma surgery patients 18 years and older at Boston Medical Center (Boston, MA) were randomized within each study group (cornea or glaucoma) to receive oral triazolam + IV placebo, or oral placebo + IV midazolam before surgery in a double-masked fashion. Supplemental IV anesthesia was administered as needed during surgery. The primary outcome measure was patient satisfaction with anesthesia, compared between oral and IV sedation groups via t-test for non-inferiority, based on 70 cornea and 43 glaucoma subjects completing the study. Secondary outcome measures included surgeon and anesthesia provider satisfaction with anesthesia, rate of supplemental IV anesthesia, and incidence of adverse events and surgical complications. RESULTS: Using an a priori non-inferiority margin of 0.5, initial oral sedation was non-inferior to initial IV sedation in cornea (n=70, p<0.001) and glaucoma (n=43, p=0.017) groups, even after excluding subjects administered supplemental IV anesthesia. There were no significant differences in anesthesia provider or surgeon satisfaction, intra-operative complications, adverse events, or supplemental anesthesia between groups, except for higher anesthesia provider satisfaction with oral sedation in an Ahmed or Baerveldt implant ± cataract surgery sub-group (p=0.04). Subjects receiving supplemental anesthesia included 6 oral (18.2%) and 5 IV (13.5%) in the cornea group (p=0.59), and 7 oral (29.2%) and 6 IV (31.6%) in the glaucoma group (p=0.50). CONCLUSION: Our results suggest that an initial dose of oral triazolam is equivalent to IV midazolam for non-cataract anterior segment surgeries. However, there was a relatively high need for supplemental IV anesthesia during some surgery types, particularly with glaucoma tube shunt implantation. |
format | Online Article Text |
id | pubmed-9274777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92747772022-07-13 Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial Lee, Hyunjoo J Desai, Manishi A Sadlak, Natalie Fiorello, Marissa G Githere, Wanjiku G Subramanian, Manju L Clin Ophthalmol Clinical Trial Report PURPOSE: To determine whether oral sedation is as safe and effective as IV sedation for ophthalmic surgeries other than cataract surgery, we tested whether patient satisfaction with oral triazolam was non-inferior to IV midazolam for cornea and glaucoma surgeries. PATIENTS AND METHODS: Seventy-five cornea and 49 glaucoma surgery patients 18 years and older at Boston Medical Center (Boston, MA) were randomized within each study group (cornea or glaucoma) to receive oral triazolam + IV placebo, or oral placebo + IV midazolam before surgery in a double-masked fashion. Supplemental IV anesthesia was administered as needed during surgery. The primary outcome measure was patient satisfaction with anesthesia, compared between oral and IV sedation groups via t-test for non-inferiority, based on 70 cornea and 43 glaucoma subjects completing the study. Secondary outcome measures included surgeon and anesthesia provider satisfaction with anesthesia, rate of supplemental IV anesthesia, and incidence of adverse events and surgical complications. RESULTS: Using an a priori non-inferiority margin of 0.5, initial oral sedation was non-inferior to initial IV sedation in cornea (n=70, p<0.001) and glaucoma (n=43, p=0.017) groups, even after excluding subjects administered supplemental IV anesthesia. There were no significant differences in anesthesia provider or surgeon satisfaction, intra-operative complications, adverse events, or supplemental anesthesia between groups, except for higher anesthesia provider satisfaction with oral sedation in an Ahmed or Baerveldt implant ± cataract surgery sub-group (p=0.04). Subjects receiving supplemental anesthesia included 6 oral (18.2%) and 5 IV (13.5%) in the cornea group (p=0.59), and 7 oral (29.2%) and 6 IV (31.6%) in the glaucoma group (p=0.50). CONCLUSION: Our results suggest that an initial dose of oral triazolam is equivalent to IV midazolam for non-cataract anterior segment surgeries. However, there was a relatively high need for supplemental IV anesthesia during some surgery types, particularly with glaucoma tube shunt implantation. Dove 2022-07-01 /pmc/articles/PMC9274777/ /pubmed/35837489 http://dx.doi.org/10.2147/OPTH.S354570 Text en © 2022 Lee et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Clinical Trial Report Lee, Hyunjoo J Desai, Manishi A Sadlak, Natalie Fiorello, Marissa G Githere, Wanjiku G Subramanian, Manju L Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial |
title | Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial |
title_full | Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial |
title_fullStr | Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial |
title_full_unstemmed | Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial |
title_short | Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial |
title_sort | oral sedation is non-inferior to intravenous sedation for cornea and glaucoma surgery: a randomized controlled trial |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274777/ https://www.ncbi.nlm.nih.gov/pubmed/35837489 http://dx.doi.org/10.2147/OPTH.S354570 |
work_keys_str_mv | AT leehyunjooj oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial AT desaimanishia oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial AT sadlaknatalie oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial AT fiorellomarissag oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial AT githerewanjikug oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial AT subramanianmanjul oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial AT oralsedationisnoninferiortointravenoussedationforcorneaandglaucomasurgeryarandomizedcontrolledtrial |